1-5 of 5
Hiroshi Kosugi, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Romiplostim in Patients with Acquired Aplastic Anemia Ineligible or Refractory to Immunosuppressive Therapy: Interim Analysis of Phase 2/3 Clinical Trial

Yoshiaki Tomiyama, MD, Jun Ho Jang, MD PhD, Jong-Wook Lee, MD PhD, Koji Miyazaki, MD, Koji Nagafuji, MD PhD, Kensuke Usuki, MD PhD, Nobuhiko Uoshima, MDPhD, Tomoaki Fujisaki, MD PhD, Hiroshi Kosugi, MD PhD, Itaru Matsumura, MD, Ko Sasaki, MD PhD, Masahiro Kizaki, MDPhD, Masashi Sawa, MD PhD, Michihiro Hidaka, MD PhD, Naoki Kobayashi, MD PhD, Satoshi Ichikawa, MD, Yuji Yonemura, MDPhD, Hiroyuki Keta, Akira Matsuda, MD, Keiya Ozawa, MD, Kinuko Mitani, MD, Shinji Nakao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1306.
https://doi.org/10.1182/blood-2018-99-112478
Published: 2018
Journal Articles

Phase II Study of the Bortezomib-Melphalan-Prednisolone Induction Therapy Followed By Lenalidomide-Plus-Dexamethasone Consolidation and Lenalidomide Maintenance in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma (CANDLE trial)

Tadao Ishida, MD, Shuji Ozaki, MD PhD, Hideo Kimura, MD PhD, Koumei Kubo, MD, Kazutaka Sunami, MD PhD, Naoki Takezako, MD PhD, Hiroyuki Fujita, MD PhD, Toshiaki Hayashi, MD PhD, Toru Kiguchi, MD PhD, Takeshi Kobayashi, MD, Satoshi Yamamoto, MD PhD, Hiroyuki Takamatsu, MD PhD, Hiroshi Kosugi, MD PhD, Kensuke Ohta, MD PhD, Rika Sakai, MD PhD, Hiroshi Handa, MD PhDChief Division, Takashi Hisatomi, MD PhD, Yu Abe, MD, Ko Sasaki, MD PhD, Eijiro Omoto, MD PhD, Hirokazu Murakami, MDPhDProf, Kazuyuki Shimizu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3121.
https://doi.org/10.1182/blood.V130.Suppl_1.3121.3121
Published: 2017
Journal Articles

Pomalidomide Plus Dexamethasone (Pd) in the Treatment of Asian Patients with Relapsed/Refractory Myeloma (RRMM) Who Are Previously Treated with Bortezomib and Refractory to Lenalidomide - Interim Analysis of a Trial By the Asian Myeloma Network (AMN)

Wee J Chng, MD MRCP, FRCPATH, PhD, Kihyun Kim, MD PhD, Jeffrey Huang, Chor Sang Chim, MBChB, Hiroshi Kosugi, MD PhD, Naoki Takezako, MD PhD, Junichi Sakamoto, MD PhD, Sathish Kumar Gopalakrishnan, Yuan Wei, Ling Ying Zhuo, Je-Jung Lee, Sung-Soo Yoon, MD PhD, Jin Seok Kim, MD PhD, Chang-Ki Min, Jae-Hoon Lee, Brian G M Durie
Journal: Blood
Blood (2016) 128 (22): 2130.
https://doi.org/10.1182/blood.V128.22.2130.2130
Published: 2016
Journal Articles

Six Month Treatment of Low Dose Eltrombopag Is Efficacious in Japanese Patients with Refractory Chronic Immune Thrombocytopenic Purpura (ITP).

Yoshiaki Tomiyama, MD, Yoshitaka Miyakawa, MD, PhD, Shinichiro Okamoto, MD, PhD, Shinya Katsutani, MD, Akiro Kimura, MD, Yasushi Okoshi, MD, PhD, Haruhiko Ninomiya, MD, PhD, Hiroshi Kosugi, MD, PhD, Shosaku Nomura, MD, Katsutoshi Ozaki, MD, Yasuo Ikeda, MD, Nobuyuki Koh, Koichi Katsura, MD, PhD, Yuzuru Kanakura, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1324.
https://doi.org/10.1182/blood.V114.22.1324.1324
Published: 2009
Journal Articles

Evaluation of Central Nervous System Recurrence of Intravascular Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Kazuyuki Shimada, MD, Takuhei Murase, MD, Kosei Matsue, MD, Masataka Okamoto, MD, Naoaki Ichikawa, MD, Norifumi Tsukamoto, MD, PhD, Ako Kikuchi, MD, Yoshio Saburi, MD, Yasufumi Masaki, MD, PhD, Nozomi Niitsu, MD, Hiroshi Miwa, MD, Hideki Asaoku, MD, Hiroshi Kosugi, MD, PhD, Morio Matsumoto, MD, Makoto Kashimura, MD, Takashi Yoshida, MD, Kazuo Tamura, MD, Kazuhito Yamamoto, MD, Motoko Yamaguchi, MD, PhD, Shigeo Nakamura, MD, Tomoki Naoe, MD, Tomohiro Kinoshita, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 4933.
https://doi.org/10.1182/blood.V112.11.4933.4933
Published: 2008